Abstract Background β-d-N4-Hydroxycytidine (NHC) is the active metabolite of molnupiravir,
a broad-spectrum antiviral approved by the MHRA for COVID-19 treatment. NHC induces …

Although vaccination for “Coronavirus disease 2019” is currently available, effective antiviral
therapy is of great importance. The presence of easily administrated oral antivirals was a …

Molnupiravir for treating COVID‐19 - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

Nirmatrelvir boosted with Ritonavir is the recommended and preferred treatment for COVID-
19. Because real-world evidence of Nirmatrelvir's antiviral activity against the Omicron …

The key goal of this mini review article is to provide enough data and info on the several
clinical trials conducted in some number of countries in the Asia on the use of the drug …

The coronavirus disease 2019 (COVID-19) represents a global public health burden. In
addition to vaccination, safe and efficient antiviral treatment strategies to restrict the viral …

Introduction The COVID-19 pandemic has been a major concern worldwide; however, easily
accessible treatment options for patients with mild COVID-19 remain limited. Since the oral …

Worldwide, the COVID-19 pandemic, caused by the brand-new coronavirus SARS-CoV-2,
has claimed a sizable number of lives. The virus' rapid spread and impact on every facet of …

Influenza virus and SARS-CoV-2 virus are two important viruses that cause respiratory tract
diseases. The high-frequency mutation of the two types of viruses leads to failure of the …

COVID-19 is an infectious disease that is caused by coronavirus SARS-CoV-2. As the time
passed it became clear that, aside from the vaccines, other efficient methods of fighting the …